139 related articles for article (PubMed ID: 9577289)
21. [The effect of ranitidine on gastric pH measured by continuous monitoring over 24 hours in healthy subjects. Comparison of 2 methods of administration: 150 mg morning and night, vs 300 mg in a single dose at night].
Bonfils S; Guedon C; Vallot T; Congard P; Garcia del Risco F; Galmiche JP; Denis P; Pappo M
Ann Gastroenterol Hepatol (Paris); 1988 Oct; 24(5):221-5. PubMed ID: 3207350
[TBL] [Abstract][Full Text] [Related]
22. A graded combination regimen for maintenance of gastric pH above 3.5 in critically ill patients.
Morris RW; Boyle M; Jacobs S; Torda T
Anaesth Intensive Care; 1991 Feb; 19(1):79-83. PubMed ID: 2012300
[TBL] [Abstract][Full Text] [Related]
23. Oral ranitidine and duration of gastric pH >4.0 in infants with persisting reflux symptoms.
Salvatore S; Hauser B; Salvatoni A; Vandenplas Y
Acta Paediatr; 2006 Feb; 95(2):176-81. PubMed ID: 16449023
[TBL] [Abstract][Full Text] [Related]
24. Immediate acid-suppressing effects of ranitidine hydrochloride and rabeprazole sodium following initial administration and reintroduction: A randomized, cross-over study using wireless pH monitoring capsules.
Ono S; Kato M; Ono Y; Imai A; Yoshida T; Shimizu Y; Asaka M
J Gastroenterol Hepatol; 2009 Apr; 24(4):639-45. PubMed ID: 19032447
[TBL] [Abstract][Full Text] [Related]
25. Ranitidine versus cimetidine prior to emergency obstetric anesthesia.
Osman H
Middle East J Anaesthesiol; 1995 Jun; 13(2):205-11. PubMed ID: 7476742
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the effects of oral famotidine and ranitidine on gastric volume and pH.
Dubin SA; Silverstein PI; Wakefield ML; Jense HG
Anesth Analg; 1989 Nov; 69(5):680-3. PubMed ID: 2572186
[No Abstract] [Full Text] [Related]
27. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
Abdul-Hussein M; Freeman J; Castell D
Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
[TBL] [Abstract][Full Text] [Related]
28. Ranitidine or dobutamine alone or combined has no effect on gastric intramucosal-arterial PCO(2) difference after cardiac surgery.
Väisänen O; Ruokonen E; Parviainen I; Bocek P; Takala J
Intensive Care Med; 2000 Jan; 26(1):45-51. PubMed ID: 10663279
[TBL] [Abstract][Full Text] [Related]
29. Use of Point-of-Care Gastric pH Testing to Assess the Efficacy of Acid Suppression Therapy in the Neonatal Intensive Care Unit.
Ekhaguere OA; Padula MA; Jensen EA
Am J Perinatol; 2020 Mar; 37(4):415-420. PubMed ID: 30780184
[TBL] [Abstract][Full Text] [Related]
30. [Role of the twenty-four-hour esophageal multichannel intraluminal impedance-pH monitoring in preterm infants].
Zhang J; Li Z; Ge Y; Wang K; Xu Z; Xia Z; Duan L
Zhonghua Er Ke Za Zhi; 2014 Apr; 52(4):298-302. PubMed ID: 24915919
[TBL] [Abstract][Full Text] [Related]
31. Dose-response effects of intravenous ranitidine on gastric pH and volume in outpatients.
Manchikanti L; Colliver JA; Grow JB; Demeyer RG; Hadley CH; Roush JR
Anesthesiology; 1986 Aug; 65(2):180-5. PubMed ID: 3740506
[TBL] [Abstract][Full Text] [Related]
32. [Randomized, open label study on the use of ranitidine at different doses for the management of weight gain associated with olanzapine administration].
López-Mato A; Rovner J; Illa G; Vieitez A; Boullosa O
Vertex; 2003; 14(52):85-96. PubMed ID: 12883589
[TBL] [Abstract][Full Text] [Related]
33. Achieving pH control in the critically ill patient: the role of continuous infusion of H2-receptor antagonists.
Moore JG
DICP; 1990 Nov; 24(11 Suppl):S28-30. PubMed ID: 1980180
[TBL] [Abstract][Full Text] [Related]
34. Randomized, prospective trial of cimetidine and ranitidine for control of intragastric pH in the critically ill.
More DG; Raper RF; Munro IA; Watson CJ; Boutagy JS; Shenfield GM
Surgery; 1985 Feb; 97(2):215-24. PubMed ID: 3881838
[TBL] [Abstract][Full Text] [Related]
35. Ranitidine prophylaxis in acute gastric mucosal damage in critically ill pediatric patients.
Lopez-Herce Cid J; Albajara Velasco L; Codoceo R; Delgado Dominguez MA; Jimenez E; Ruza Tarrio F
Crit Care Med; 1988 Jun; 16(6):591-3. PubMed ID: 3371023
[TBL] [Abstract][Full Text] [Related]
36. Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing: characterization of tolerance.
Mathôt RA; Geus WP
Clin Pharmacol Ther; 1999 Aug; 66(2):140-51. PubMed ID: 10460068
[TBL] [Abstract][Full Text] [Related]
37. Effect of Sustained Elevated Gastric pH Levels on Gefitinib Exposure.
Tang W; Tomkinson H; Masson E
Clin Pharmacol Drug Dev; 2017 Sep; 6(5):517-523. PubMed ID: 28176470
[TBL] [Abstract][Full Text] [Related]
38. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423
[TBL] [Abstract][Full Text] [Related]
39. Selenium Supplementation for Prevention of Late-Onset Sepsis in Very Low Birth Weight Preterm Neonates.
Aggarwal R; Gathwala G; Yadav S; Kumar P
J Trop Pediatr; 2016 Jun; 62(3):185-93. PubMed ID: 26867560
[TBL] [Abstract][Full Text] [Related]
40. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
Savarino V
Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
